|
|
Acyclovir (Zovirax) versus Other Medications
Acyclovir vs. Valaciclovir (Valtrex)
- Recurrent genital herpes: The study has demonstrated that
valaciclovir 500 mg twice daily is equivalent in efficacy to aciclovir
200 mg five times daily as episodic treatment of recurrent genital
HSV infection. Valaciclovir maintains the established efficacy and
safety of aciclovir but offers a much more convenient twice daily
dosing regimen. 1
- First-episode genital herpes: Twice-daily valaciclovir is
as effective and well tolerated in the treatment of first-episode
genital herpes as five-times-daily acyclovir. Valaciclovir provides
a useful alternative to acyclovir with the advantage of a more convenient
dosing regimen and the potential for improved compliance.2
- Suppression of HSV shedding: Although the suppression of
viral replication is not complete, valacyclovir and acyclovir are
highly effective in suppressing the frequency and quantity of genital
HSV shedding. No significant differences in frequency and quantity
of HSV were detected by polymerase chain reaction (PCR) between the
valacyclovir and acyclovir. 3
- Herpes zoster: The study showed that valaciclovir significantly
accelerate the resolution of herpes zoster-associated pain compared
with acyclovir. In the management of herpes zoster valaciclovir is
superior to acyclovir.5
- Post-transplantation cytomegalovirus prophylaxis: Valacyclovir
appears to be more effective than acyclovir in preventing CMV reactivation
in bone marrow transplant recipients. 4
Acyclovir vs. Famciclovir (Famvir)
- Herpes zoster: Acyclovir and famciclovir have comparable
efficacy and similar adverse effect profile.
In the clinical study there was no significant differences between
the four treatment regiments (famciclovir 750 mg once daily, 500 mg
twice daily and 250 mg daily, and aciclovir 800 mg five times daily)
with respect to times to full crusting; loss of vesicles, ulcers and
crusts; cessation of new lesion formation; a 50% reduction in the
area of affected skin; and the loss of acute pain. 6
The pharmacokinetics of famciclovir allow a more convenient dosing
schedule than the schedule used with acyclovir.
Acyclovir vs. Penciclovir (Denavir) (Topical)
- Herpes labialis (cold sores): In comparative model the efficacy
of penciclovir cream was greater than acyclovir cream. 7
- Genital herpes: The results of the study showed that there
is no significant differences in clinical efficacy between penciclovir
1% cream and acyclovir 3% cream with respect to clinical cure rate,
times to healing, resolution of all symptoms, absence of blisters,
cessation of new blisters, crusting, and loss of crust. However a
significantly shorter time to crusting was found with penciclovir
when compared with acyclovir. Adverse experience was was comparable
with two medications. 8
Further reading
References
- 1. Bodsworth NJ, Crooks RJ, Borelli S, Vejlsgaard G, Paavonen J,
Worm AM, Uexkull N, Esmann J, Strand A, Ingamells AJ, Gibb A. Valaciclovir
versus aciclovir in patient initiated treatment of recurrent genital
herpes: a randomised, double blind clinical trial. International Valaciclovir
HSV Study Group. Genitourin Med. 1997 Apr;73(2):110-6. PubMed
- 2. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir
versus acyclovir in the treatment of first-episode genital herpes
infection. Results of an international, multicenter, double-blind,
randomized clinical trial. The Valaciclovir International Herpes Simplex
Virus Study Group. Sex Transm Dis. 1997 Sep;24(8):481-6. PubMed
- 3. Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M,
Miller G, Corey L. Valacyclovir and acyclovir for suppression of shedding
of herpes simplex virus in the genital tract. J Infect Dis. 2004 Oct
15;190(8):1374-81. Epub 2004 Sep 20. PubMed
- 4. Ljungman P, de La Camara R, Milpied N, Volin L, Russell CA, Crisp
A, Webster A; Valacyclovir International Bone Marrow Transplant Study
Group. Randomized study of valacyclovir as prophylaxis against cytomegalovirus
reactivation in recipients of allogeneic bone marrow transplants.
Blood. 2002 Apr 15;99(8):3050-6. PubMed
- 5. Lin WR, Lin HH, Lee SS, Tsai HC, Huang CK, Wann SR, Chen YS,
Chiang SC, Yen MY, Liu YC. Comparative study of the efficacy and safety
of valaciclovir versus acyclovir in the treatment of herpes zoster.
J Microbiol Immunol Infect. 2001 Jun;34(2):138-42. PubMed
- 6. Shafran SD, Tyring SK, Ashton R, Decroix J,
Forszpaniak C, Wade A, Paulet C, Candaele D. Once, twice, or three
times daily famciclovir compared with aciclovir for the oral treatment
of herpes zoster in immunocompetent adults: a randomized, multicenter,
double-blind clinical trial. J Clin Virol. 2004 Apr;29(4):248-53.
PubMed
- 7. McKeough MB, Spruance SL. Comparison of new
topical treatments for herpes labialis: efficacy of penciclovir cream,
acyclovir cream, and n-docosanol cream against experimental cutaneous
herpes simplex virus type 1 infection. Arch Dermatol. 2001 Sep;137(9):1153-8.
PubMed
- 8. Chen XS, Han GZ, Guo ZP, Lu NZ, Chen J, Wang
JB; Penciclovir Multicenter Genital Herpes Clinical Study Group. A
comparison of topical application of penciclovir 1% cream with acyclovir
3% cream for treatment of genital herpes: a randomized, double-blind,
multicentre trial. Int J STD AIDS. 2000 Sep;11(9):568-73. PubMed
|